Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly.See plans and pricing.See plans →
Mycelium-based paving material developer Visibuilt raises €3.34 million in Seed funding, co-led by EIFO and Unconventional Ventures, to advance towards market validation.
Visibuilt, a Danish BioTech company, has secured €3.34 million in Seed funding to move from lab pilots towards market validation and industry tests. The round was co-led by EIFO and Unconventional Ventures, followed by Proptechfonden and earlier investor EMDFonden. This funding is aimed at maturing their technical platform for larger scale validation. Visibuilt aims to address the significant CO₂ emissions from concrete and asphalt production.
Company Information
Company
Visibuilt
Location
Denmark
About
Visibuilt is a Danish BioTech company founded in 2022 that develops mycelium-based binder solutions for the construction and infrastructure industries. The company's technology, visiBINDER, offers lower-carbon alternatives to conventional paving materials. Visibuilt combines biotechnology and material science to create innovative solutions designed to reduce CO₂ emissions in heavy industries.
Don't miss Visibuilt's next move
Get an email the moment Visibuilt raises, hires an exec, or expands, usually minutes after it happens.
DenmarkBiotechnology